Dialogue Health Technologies Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CAD 87.13 million compared to CAD 64.53 million a year ago. Net loss was CAD 25.95 million compared to CAD 251.35 million a year ago.

Basic loss per share from continuing operations was CAD 0.37 compared to CAD 4.42 a year ago. Basic loss per share was CAD 0.39 compared to CAD 4.48 a year ago.